Arrowhead Pharmaceuticals (HDP1.F) Q3 2024 Earnings

8AugConfirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-1.75
-1.31
-0.87
-0.44

Details

Expected EPS
-0.48450242127000004
Actual EPS
-1.2640938
Surprise EPS
-0.78
Surprise Percent
+160.91%

Description

Arrowhead Pharmaceuticals (HDP1.F) has reported earnings of -1.2640938 per share for Q3 2024.

0 Comments

Share your thoughts